Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

New Nordic nutrition collaboration

Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.

Satsar på tidig forskning

Tillsammans med tre universitet skapar Astrazeneca, GSK och Johnson and Johnson en fond för utveckling av prekliniska projekt.

Sprint får ny vetenskaplig rådgivare

Cancerforskaren Ravi Amaravadi från USA ska hjälpa bolaget till klinisk fas.

535 miljoner till regenerativ medicin

Knut och Alice Wallenbergs Stiftelse finansierar ett nytt forskningscentrum i Lund.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Här testas tekniker för framtidens tillverkning

Biologiska läkemedel är världens snabbast växande klass av läkemedel. Sverige vill hänga på. Men då räcker det inte med innovativa molekyler. Vi måste bli bra p...

Seminar program Biotech Forum

Here is the entire seminar program at Biotech Forum September 28-29th

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

Första Crispr-bolaget till börsen

Editas Medicine blir det första bolaget på börsen med fokus på det omtalade genmodifieringsverktyget Crispr/Cas9.

Sales Representative, Applied Biosystems

Stöd till kvinnliga forskare

17 kvinnliga forskare får halva lönen betald för att jobba i en ledande forskningsmiljö i Vinnova-programmet Vinnmer.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Raysearch igång i Kina

Första patienten ombord i strålstudie.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Many rotor options for refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Blood type decide resistance to HIV

A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.

Multiple rotor options in refrigerated microcentrifuge

The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.

Få överraskningar i rapporten

Pledpharmas kvartalsrapport bjöd inte på några stora nyheter men planerna på diskussioner med FDA och potentiella samarbetspartners ligger fast.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.